Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema.
Valérie SardaPauline EymardLinda HraratFranck FajnkuchenAudrey Giocanti-AuréganPublished in: Journal of ophthalmology (2020)
In DME patients, the CSCT decreases after 5 IVI of anti-VEGF, especially after aflibercept treatment.